RA CAPITAL MANAGEMENT, L.P. — Form SCHEDULE 13D/A
Filed July 2, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 24/100
What the filing says
RA Capital Management, L.P. filed an amended Schedule 13D/A on July 2, 2026, regarding its beneficial ownership position in Werewolf Therapeutics, Inc. (a pharmaceutical preparations company). The filing document itself does not contain the specific amendments, share counts, percentage ownership, or dollar amounts — only metadata confirming the amendment was submitted.
Why this rating
Amendment to an existing 13D is routine disclosure. Without specifics on ownership changes or thresholds crossed, cannot assess materiality to Werewolf's business.
View original filing on SEC.gov ↗
See more from July 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.